Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Half-year results 2024 of SartoriusStedimBiotech
Half-year results 2024 of SartoriusStedimBiotech
Half-year results 2024 of SartoriusStedimBiotech
Sartorius Stedim Biotech SA: Sartorius Stedim Biotech adjusts its guidance for fiscal year 2024 and presents results for H1 2024
Sartorius Stedim Biotech SA: Sartorius Stedim Biotech adjusts its guidance for fiscal year 2024 and presents results for H1 2024
Sartorius Stedim Biotech SA: Sartorius Stedim Biotech adjusts its guidance for fiscal year 2024 and presents results for H1 2024
FOCUS ENTERTAINMENT: 2024/25 first-quarter revenue of €34.2m, driven by  a solid back-catalogue up sharply by 17%
FOCUS ENTERTAINMENT: 2024/25 first-quarter revenue of €34.2m, driven by a solid back-catalogue up sharply by 17%
FOCUS ENTERTAINMENT: 2024/25 first-quarter revenue of €34.2m, driven by a solid back-catalogue up sharply by 17%
EQS-News: Abivax Provides Operational and Key Program Update
EQS-News: Abivax Provides Operational and Key Program Update
EQS-News: Abivax Provides Operational and Key Program Update
Kaufman & Broad SA: NEW SYNDICATED LOAN AGREEMENT FOR €200M OVER 5 YEARS
Kaufman & Broad SA: NEW SYNDICATED LOAN AGREEMENT FOR €200M OVER 5 YEARS
Kaufman & Broad SA: NEW SYNDICATED LOAN AGREEMENT FOR €200M OVER 5 YEARS
Poxel Provides an Update on Its Financial Position for the Second Quarter and First Half of 2024 and Announces the Rescheduling of Its Annual General Meeting: https://mms.businesswire.com/media/20210929005940/en/578635/5/POXEL_LOGO_Q.jpg
Poxel Provides an Update on Its Financial Position for the Second Quarter and First Half of 2024 and Announces the Rescheduling of Its Annual General Meeting


Regulatory News:



POXEL SA (Euronext : POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic

Sensorion Announces New Positive Secondary Efficacy Endpoints Data From SENS-401 Phase 2a Clinical Trial For The Preservation Of Residual Hearing Loss: https://mms.businesswire.com/media/20210609005851/en/705797/5/logo-sensorion2.jpg
Sensorion Announces New Positive Secondary Efficacy Endpoints Data From SENS-401 Phase 2a Clinical Trial For The Preservation Of Residual Hearing Loss


Regulatory News:



Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within

Kaufman & Broad SA: RESULTS FOR THE 1ST HALF YEAR OF 2024
Kaufman & Broad SA: RESULTS FOR THE 1ST HALF YEAR OF 2024
Kaufman & Broad SA: RESULTS FOR THE 1ST HALF YEAR OF 2024
GenSight Biologics Launches Newsletter for Retail Investors: https://mms.businesswire.com/media/20191208005050/en/761225/5/Logo+Centre+Hospitalier+XV-XX.jpg
GenSight Biologics Launches Newsletter for Retail Investors


Regulatory News:



GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal

Hy-Vee Focusing on Digital Transformation and Sustainability with VusionGroup Technology: https://mms.businesswire.com/media/20240110589886/en/1995468/5/Vusion_Group_Wordmark_Vusion_Black_CMYK.jpg
Hy-Vee Focusing on Digital Transformation and Sustainability with VusionGroup Technology


Hy-Vee, an employee-owned company operating more than 570 business units across nine Midwestern states with sales of more than $13 billion annually, has implemented a series of digital solutions

Bauer Stadium : REALITES entering Exclusive Negotiations with TODD INTERESTS
Bauer Stadium : REALITES entering Exclusive Negotiations with TODD INTERESTS
Bauer Stadium : REALITES entering Exclusive Negotiations with TODD INTERESTS
Kaufman & Broad SA: HALF-YEAR 2024 JUNE 30 - LIQUIDITY CONTRACT STATEMENT FOR KAUFMAN & BROAD SA
Kaufman & Broad SA: HALF-YEAR 2024 JUNE 30 - LIQUIDITY CONTRACT STATEMENT FOR KAUFMAN & BROAD SA
Kaufman & Broad SA: HALF-YEAR 2024 JUNE 30 - LIQUIDITY CONTRACT STATEMENT FOR KAUFMAN & BROAD SA
"Because we care": Pernod Ricard unveils its Responsible Host certification at its Brand Homes and its desire to champion responsible drinking: https://mms.businesswire.com/media/20200212005993/en/773259/5/Createurs_de_Convivialite.jpg
"Because we care": Pernod Ricard unveils its Responsible Host certification at its Brand Homes and its desire to champion responsible drinking


Regulatory News:



Pernod Ricard (Paris:RI):



Press release – Paris, 4th July 2024



As Créateurs de convivialité, Pernod Ricard is proud to roll-out the first Responsible Host Certification

BILAN SEMESTRIEL – S1 2024 – DU CONTRAT DE LIQUIDITE
BILAN SEMESTRIEL – S1 2024 – DU CONTRAT DE LIQUIDITE
BILAN SEMESTRIEL – S1 2024 – DU CONTRAT DE LIQUIDITE
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO  THE NUMBER OF SHARES AND VOTING RIGHTS  MAKING UP THE ISSUED CAPITAL
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Sartorius Stedim Biotech SA: Half-year liquidity contract statement for Sartorius Stedim Biotech
Sartorius Stedim Biotech SA: Half-year liquidity contract statement for Sartorius Stedim Biotech
Sartorius Stedim Biotech SA: Half-year liquidity contract statement for Sartorius Stedim Biotech
Dassault Systèmes and Mistral AI Partner to Offer Trusted, AI-Powered Industry-Grade Solutions to Accelerate the Generative Economy: https://mms.businesswire.com/media/20191104005004/en/734381/5/3DS_Corp_Logotype_Blue_RGB.jpg
Dassault Systèmes and Mistral AI Partner to Offer Trusted, AI-Powered Industry-Grade Solutions to Accelerate the Generative Economy


Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) and Mistral AI today announced their partnership to bring the full power of frontier AI to industries in a trusted environment.



For more

FOCUS ENTERTAINMENT: Financial calendar 2024/25
FOCUS ENTERTAINMENT: Financial calendar 2024/25
FOCUS ENTERTAINMENT: Financial calendar 2024/25
Sensorion Announces the Appointment of Laurene Danon as Chief Financial Officer: https://mms.businesswire.com/media/20210609005851/en/705797/5/logo-sensorion2.jpg
Sensorion Announces the Appointment of Laurene Danon as Chief Financial Officer


Regulatory News:



Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within

Mauna Kea Technologies Unveils CellTolerance, a Subsidiary Dedicated to its Unique Program for the Detection and Treatment of Food Intolerances: https://mms.businesswire.com/media/20240626399128/en/337855/5/mkt_logo_bg_1024-300dpi.jpg
Mauna Kea Technologies Unveils CellTolerance, a Subsidiary Dedicated to its Unique Program for the Detection and Treatment of Food Intolerances


Regulatory News:



Mauna Kea Technologies (Euronext Growth: ALMKT), inventor of Cellvizio®, the multidisciplinary platform for probe-based and needle-based confocal laser endomicroscopy (p/nCLE)

Verimatrix erhält renommierten StreamTV-Preis für seine Cybersicherheits- und Anti-Piraterie-Technologien: https://mms.businesswire.com/media/20200603005395/en/795668/5/VMX+logo+4210606c.jpg
Verimatrix erhält renommierten StreamTV-Preis für seine Cybersicherheits- und Anti-Piraterie-Technologien


Verimatrix, (Euronext Paris: VMX, FR0010291245) (Paris:VMX), der führende Anbieter von Sicherheitstechnologien für Menschen in der modernen vernetzten Welt, gab heute bekannt, dass seine Suite

Verimatrix Wins Prestigious StreamTV Award for its Cybersecurity and Anti-Piracy Technologies: https://mms.businesswire.com/media/20200603005395/en/795668/5/VMX+logo+4210606c.jpg
Verimatrix Wins Prestigious StreamTV Award for its Cybersecurity and Anti-Piracy Technologies


Regulatory News:



Verimatrix, (Euronext Paris: VMX, FR0010291245) (Paris:VMX), the leader in powering the modern connected world with people-centered security, today announced its Verimatrix

Verimatrix präsentiert die Plattform zum Schutz mobiler Apps auf den OWASP-Veranstaltungen in Lissabon und San Francisco: https://mms.businesswire.com/media/20200603005395/en/795668/5/VMX+logo+4210606c.jpg
Verimatrix präsentiert die Plattform zum Schutz mobiler Apps auf den OWASP-Veranstaltungen in Lissabon und San Francisco


Verimatrix, (Euronext Paris: VMX, FR0010291245), der führende Anbieter von Sicherheit für die moderne vernetzte Welt, gab heute seine Teilnahme an zwei führenden Veranstaltungen des Open Worldwide

Verimatrix To Showcase Mobile App Protection Platform at OWASP Events in Lisbon and San Francisco: https://mms.businesswire.com/media/20200603005395/en/795668/5/VMX+logo+4210606c.jpg
Verimatrix To Showcase Mobile App Protection Platform at OWASP Events in Lisbon and San Francisco


Regulatory News:



Verimatrix, (Euronext Paris: VMX, FR0010291245), the leader in powering the modern connected world with people-centered security, today announced its participation in two

Edison issues report on Amoéba (ALMIB)
Edison issues report on Amoéba (ALMIB)
Edison issues report on Amoéba (ALMIB)